AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients with hard-to-treat autoimmune anemia?
Disease control Not yet recruitingThis early-phase study tests a new drug, enatumab, in 3 adults with relapsed or refractory warm antibody autoimmune hemolytic anemia (wAIHA), a condition where the immune system attacks red blood cells. Current treatments often stop working or cause side effects. The goal is to s…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2 • Sponsor: Bing Han • Aim: Disease control
Last updated May 17, 2026 04:24 UTC
-
New cell therapy offers hope for hard-to-treat blood disorder
Disease control Not yet recruitingThis early-phase trial tests a new cell treatment called YTS109 for people with a severe type of anemia where the immune system attacks red blood cells. It is for patients who have not improved after at least three other treatments. The study will check if the therapy is safe and…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
New cell therapy offers hope for Hard-to-Treat blood disorder
Disease control Not yet recruitingThis early-stage trial tests a new cell therapy called YTS109 for people with autoimmune hemolytic anemia that hasn't improved after three or more treatments. The therapy uses specially designed immune cells to target and destroy the faulty cells attacking red blood cells. The st…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New pill shows promise for rare blood disorder
Disease control Not yet recruitingThis study tests a new oral drug, linprixel, in 22 adults with autoimmune hemolytic anemia that has not responded to or returned after other treatments. The drug aims to control the disease by reducing the immune system's attack on red blood cells. Participants take the drug dail…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
Phase i clinical study on the safety and tolerability of IASO206 injection in patients with Relapsed/Refractory autoimmune hemolytic anemia
Not yet recruitingThis study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection (In Vivo CAR-T) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Last updated May 17, 2026 04:10 UTC